Skip to content or view screen version

Hidden Article

This posting has been hidden because it breaches the Indymedia UK (IMC UK) Editorial Guidelines.

IMC UK is an interactive site offering inclusive participation. All postings to the open publishing newswire are the responsibility of the individual authors and not of IMC UK. Although IMC UK volunteers attempt to ensure accuracy of the newswire, they take no responsibility legal or otherwise for the contents of the open publishing site. Mention of external web sites or services is for information purposes only and constitutes neither an endorsement nor a recommendation.

Shamrock Structures Names Richard L. Walter, Ph.D. as Chief Scientific Officer

Mr Roger K. Olsson | 22.07.2007 22:43 | Analysis | Other Press | London | World

Giuen Media



Tuesday, July 17, 2007


CHICAGO, Jul. 17, 2007 (Business Wire) -- Shamrock Structures LLC, a privately held structural biology company, announced today that Richard L. Walter, Ph.D. has been appointed to the position of Chief Scientific Officer.

Dr. Walter will be responsible for overseeing all scientific activities in structural biology R&D, enabling Shamrock to provide complete gene-to-structure services to its pharmaceutical company clients. He will direct the further development of the Company's scientific vision, laboratory operations and scientific management.

'I am delighted that Rick is joining Shamrock Structures as CSO. He is highly regarded by his peers in the pharmaceutical industry and brings excellent scientific leadership experience, as well as a great deal of energy and enthusiasm. Rick will play a vital role in our initiative to become a leading structural biology and protein crystallography services company,' said Steven J. Schiltz, CEO of Shamrock Structures.

'I am very impressed by Shamrock Structures' establishing itself as a key provider in protein crystallography and synchrotron beamline services and I am invigorated by the commitment to expand and grow the company,' said Dr. Walter. 'I look forward to shepherding Shamrock's scientific endeavors and spearheading the execution of full gene-to-structure services to deliver the greatest value to clients conducting structure-based drug discovery.'

Dr. Walter is formally trained as a protein crystallographer and protein biochemist and has over ten years industrial experience working in pharmaceutical and consumer products research. He was most recently Associate Research Fellow at Pfizer's Ann Arbor, Michigan Laboratories, where he had responsibility for group management and implementation of gene-to-structure capability. Prior to Pfizer, he was at The Procter & Gamble Company for nine years, where he led structural biology and protein crystallography teams in a variety of gene-to-structure projects.

Dr. Walter received his Ph.D. in Biochemistry, focused in X-ray crystallography, at Cornell University in Ithaca, New York under the mentorship of Stephen E. Ealick, Ph.D. After completing his Ph.D., he was a Senior Postdoctoral Fellow at Purdue University in West Lafayette, Indiana, where he helped design, build and establish new crystallography and biochemistry laboratories. He received his B.A. in Biology/Biochemistry at the College of Wooster in Wooster, Ohio. He has published and presented extensively in the fields of structural biology and protein crystallography.

Shamrock Structures, LLC, (www.shamrockstructures.com) is a privately held, structural biology, protein crystallography and synchrotron beamline services company that determines the three dimensional structures of proteins and protein complexes. The Company offers integrated gene-to-structure services and efficient access to X-ray synchrotron data collection, enabling pharmaceutical clients to decrease the time required to advance from protein targets to novel drug development.

Newstex ID: BW-0001-18184628


Delivered by Newstex LLC
via theFinancials.com

Mr Roger K. Olsson
- e-mail: rogerkolsson@yahoo.co.uk
- Homepage: http://giuen.wordpress.com